BMC Dermatology

Table 1 Changes in MASI scores of tested drugs in melasma patients

From: The treatment of melasma by silymarin cream

		MASI
Treatment	Baseline	After 1^stweek	After 2^nd week	After 3^rd week	After 4^th week
G I: SM 7 mg/ml	17.1 ± 3.12	12.3 ± 2.3^a	6.6 ± 2.4^b	0.2 ± 1.72^b	0^b
G II: SM 14 mg/ml	16.5 ± 2.8	10.4 ± 1.2^a	3.5 ± 1.4^b	0^b	0^b
G III: Placebo	16.8 ± 3.2	16.8 ± 3.3^c	16.8 ± 3.5^c	17 ± 3.4^c	17 ± 3.4^c

^a p ≤ 0.01, ^b p ≤ 0.0001, ^c p ≥ 0.05.

Back to article page

ISSN: 1471-5945

Contact us

General enquiries: ORSupport@springernature.com